Denmark· DK-28107139624
BioBhyo
A qi09ab19 product containing brachyspira hyodysenteriae, stamme aqdysh57, inaktiveret, registered in Denmark by Aquilon Cyl S.L..
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Brachyspira hyodysenteriae, stamme AqDysH57, inaktiveret
- Manufacturer
- Aquilon Cyl S.L.
- Country
- Denmark (DK)
- ATC code
- QI09AB19
- ATC class
- QI09AB19
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28107139624
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d9e3e597-04f3-44d4-8116-1def1a30bc6e GET /v1/drugs/d9e3e597-04f3-44d4-8116-1def1a30bc6e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "injektionsvæske, emulsion",
"source": "dkma",
"strength": "≥1 RP",
"auth_role": "MOD",
"dk_drugid": "28107139624",
"substance": "Brachyspira hyodysenteriae, stamme AqDysH57, inaktiveret",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "45868"
}See everything about brachyspira hyodysenteriae, stamme aqdysh57, inaktiveret.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.